Marina Ripamonti
- Molecular Biology
- Radiology, Nuclear Medicine and Imaging top 10%
- Oncology
- Organic Chemistry
- Biomaterials top 10%
- Co-authors
- Silvana CanevariMaria GrandiF. SpreaficoM. FaraoRosaria OrlandiKarel UlbrichAntonino SuaratoLeonard W. Seymour
- Topics
- Monoclonal and Polyclonal Antibodies Research (8 papers)Cancer therapeutics and mechanisms (6 papers)Toxin Mechanisms and Immunotoxins (4 papers)
- Journals
- JNCI Journal of the National Cancer InstituteJournal of Controlled ReleaseBritish Journal of Cancer
- Partner nations
- ItalySpainUnited Kingdom
In The Last Decade
Marina Ripamonti
18 papers receiving 451 citations
Peers
Comparison fields: 5 of 60
- Molecular Biology 237
- Radiology, Nuclear Medicine and Imaging 112
- Oncology 105
- Organic Chemistry 104
- Biomaterials 92
Countries citing papers authored by Marina Ripamonti
This map shows the geographic impact of Marina Ripamonti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marina Ripamonti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marina Ripamonti more than expected).
Fields of papers citing papers by Marina Ripamonti
This network shows the impact of papers produced by Marina Ripamonti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marina Ripamonti. The network helps show where Marina Ripamonti may publish in the future.
Co-authorship network of co-authors of Marina Ripamonti
This figure shows the co-authorship network connecting the top 25 collaborators of Marina Ripamonti. A scholar is included among the top collaborators of Marina Ripamonti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marina Ripamonti. Marina Ripamonti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Pharmacological and toxicological aspects of 4-demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548): a novel antineoplastic agent. | 17 |
| 2 | 4-Demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548), a novel anticancer agent active against tumor cell lines with different resistance mechanisms. | 9 |
| 3 | 7 | |
| 4 | 66 | |
| 5 | Sequence-specific DNA interactions by novel alkylating anthracycline derivatives. | 11 |
| 6 | 3 | |
| 7 | 44 | |
| 8 | 158 | |
| 9 | 12 | |
| 10 | 4 | |
| 11 | 34 | |
| 12 | 28 | |
| 13 | 2 | |
| 14 | Monoclonal antibodies perspectives for tumor therapy | 1 |
| 15 | 17 | |
| 16 | 8 | |
| 17 | 14 | |
| 18 | 32 |
About Marina Ripamonti
Marina Ripamonti is a scholar working on Toxicology, Biotechnology and Radiology, Nuclear Medicine and Imaging, having authored 18 papers that have together received 467 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (8 papers), Cancer therapeutics and mechanisms (6 papers) and Toxin Mechanisms and Immunotoxins (4 papers). The work is most often cited by research in Biotechnology (88 citations), Biomaterials (92 citations) and Radiology, Nuclear Medicine and Imaging (112 citations). Marina Ripamonti has collaborated with scholars based in Italy, Spain and United Kingdom. Frequent co-authors include Silvana Canevari, Maria Grandi, F. Spreafico, M. Farao, Rosaria Orlandi, Karel Ulbrich, Antonino Suarato, Leonard W. Seymour, Maria I. Colnaghi and Stephen R. Wedge. Their work appears in journals such as JNCI Journal of the National Cancer Institute, Journal of Controlled Release and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.